Top

Published in:

01-01-2019 | Letter

Comment on ‘Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial’

Authors: Payam Amini, Sevda Moharamzadeh

Published in: Diabetologia | Issue 1/2019

Excerpt

To the Editor: With interest, we read a recently published article in Diabetologia by Heiskanen et al, who investigated the effect of exercise training, using pancreatic fat content (PFC) as a primary outcome and beta cell function as a secondary outcome [1]. The authors stated that, with exercise training, there was a similar decrease in PFC in healthy men and in men with prediabetes (defined as impaired fasting glucose and/or impaired glucose tolerance) or type 2 diabetes. …

Heiskanen MA, Motiani KK, Mari A et al (2018) Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial. Diabetologia 61(8):1817–1828. https://doi.org/10.1007/s00125-018-4627-x CrossRefPubMedPubMedCentral

Agresti A (2003) Categorical data analysis. John Wiley & Sons, New Jersey

Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G (2008) Longitudinal data analysis. CRC press, Boca Raton, FL

Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE (2002) Defining the relationship between plasma glucose and HbA_1c: analysis of glucose profiles and HbA_1c in the Diabetes Control and Complications Trial. Diabetes Care 25(2):275–278. https://doi.org/10.2337/diacare.25.2.275 CrossRefPubMed

Tahara Y, Shima K (1995) Kinetics of HbA_1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18(4):440–447. https://doi.org/10.2337/diacare.18.4.440 CrossRefPubMed

Paroni R, Ceriotti F, Galanello R et al (2007) Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem 40(18):1398–1405. https://doi.org/10.1016/j.clinbiochem.2007.08.001 CrossRefPubMed

Yoshiuchi K, Matsuhisa M, Katakami N et al (2008) Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 55(3):503–507. https://doi.org/10.1507/endocrj.K07E-089 CrossRefPubMed

Kohnert KD, Heinke P, Vogt L, Salzsieder E (2015) Utility of different glycemic control metrics for optimizing management of diabetes. World J Diabetes 6(1):17–29. https://doi.org/10.4239/wjd.v6.i1.17 CrossRefPubMedPubMedCentral

Title: Comment on ‘Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial’
Authors: Payam Amini
Sevda Moharamzadeh
Publication date: 01-01-2019
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 1/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-018-4765-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comment on ‘Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial’

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study

The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice

Basal fatty acid oxidation increases after recurrent low glucose in human primary astrocytes

Clinical outcomes of an integrated primary–secondary model of care for individuals with complex type 2 diabetes: a non-inferiority randomised controlled trial

Capturing residual beta cell function in type 1 diabetes

A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page